S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

NASDAQ:SGRY - Surgery Partners Stock Price, Forecast & News

$19.00
+0.77 (+4.22 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$18.25
Now: $19.00
$19.05
50-Day Range
$15.11
MA: $17.39
$19.00
52-Week Range
$5.38
Now: $19.00
$19.05
Volume444,881 shs
Average Volume398,036 shs
Market Capitalization$949.98 million
P/E RatioN/A
Dividend YieldN/A
Beta2.68
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. Read More…

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Book Value$22.48 per share

Profitability

Net Income$-205,710,000.00

Miscellaneous

Employees11,000
Market Cap$949.98 million
Next Earnings Date3/5/2020 (Confirmed)
OptionableOptionable

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.


Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) announced its earnings results on Tuesday, November, 5th. The company reported ($0.28) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.34) by $0.06. The business earned $452 million during the quarter, compared to analysts' expectations of $452.30 million. Surgery Partners had a negative return on equity of 5.32% and a negative net margin of 11.26%. The company's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter last year, the business posted ($0.19) earnings per share. View Surgery Partners' Earnings History.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Surgery Partners.

How can I listen to Surgery Partners' earnings call?

Surgery Partners will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for SGRY?

3 brokerages have issued twelve-month price objectives for Surgery Partners' stock. Their forecasts range from $12.00 to $20.00. On average, they expect Surgery Partners' stock price to reach $17.00 in the next twelve months. This suggests that the stock has a possible downside of 10.5%. View Analyst Price Targets for Surgery Partners.

What is the consensus analysts' recommendation for Surgery Partners?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.

Has Surgery Partners been receiving favorable news coverage?

Media headlines about SGRY stock have been trending neutral recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Surgery Partners earned a daily sentiment score of 0.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Surgery Partners.

Are investors shorting Surgery Partners?

Surgery Partners saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 4,520,000 shares, a decrease of 9.8% from the January 15th total of 5,010,000 shares. Based on an average daily volume of 366,200 shares, the days-to-cover ratio is currently 12.3 days. Approximately 21.9% of the company's stock are short sold. View Surgery Partners' Current Options Chain.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Verizon Communications (VZ), NVIDIA (NVDA), Advanced Micro Devices (AMD), Amarin (AMRN), Select Medical (SEM), Visa (V), Editas Medicine (EDIT), Mazor Robotics (MZOR), Xilinx (XLNX) and Bank of America (BAC).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the folowing people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by many different of retail and institutional investors. Top institutional investors include Royce & Associates LP (2.83%), Goldman Sachs Group Inc. (1.46%), Pictet Asset Management Ltd. (1.29%), State Street Corp (1.00%), Bank of America Corp DE (0.38%) and Marshall Wace LLP (0.37%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View Institutional Ownership Trends for Surgery Partners.

Which institutional investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Schonfeld Strategic Advisors LLC, Strs Ohio, Royce & Associates LP, Dimension Capital Management LLC, Victory Capital Management Inc., Victory Capital Management Inc. and Credit Suisse AG. View Insider Buying and Selling for Surgery Partners.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP, Marshall Wace LLP, State Street Corp, Public Sector Pension Investment Board, Trexquant Investment LP, California Public Employees Retirement System, Los Angeles Capital Management & Equity Research Inc. and SlateStone Wealth LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans and Teresa Deluca. View Insider Buying and Selling for Surgery Partners.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $19.00.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $949.98 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.

What is Surgery Partners' official website?

The official website for Surgery Partners is http://www.surgerypartners.com/.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]


MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  231 (Vote Outperform)
Underperform Votes:  306 (Vote Underperform)
Total Votes:  537
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel